Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...
ST. LOUIS — The Alzheimer’s Association reports that for the first time, more than 7.2 million Americans aged 65 and older are estimated to be living with Alzheimer’s disease in 2025 — a number ...
Recognizing the early signs of Alzheimer’s can feel like standing at the edge of an emotional cliff — overwhelming, terrifying and confusing all at once. But knowing how to respond to early ...
Dr. Martínez-Lage shares Alzheimer's breakthroughs: why early diagnosis matters, the 4-step treatment plan for autonomy, and ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
The Brighterside of News on MSN
New study finds 40Hz sensory stimulation may benefit some Alzheimer’s patients for years
A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...
It’s hard to cruise your For You feed right now without being faced with yet another testimonial about the perks of taking a creatine supplement. While creatine is the supplement du jour, there is ...
Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The drug, Lecanemab, could be available to some Ottawa patients within months. But it is not yet covered by provincial drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results